
Gates Foundation Makes Start-Up Equity Investment - Are You Ready for Aerosol Vaccines?
Become a member: Subscribe
Solari’s Building Wealth materials are organized to inspire and support your personal strategic and financial planning.

Missing Money
Articles and video discussions of the $21 Trillion dollars missing from the U.S. government
No posts
Gates Foundation Makes Start-Up Equity Investment – Are You Ready for Aerosol Vaccines?
By Luke Timmerman
Global health innovators have a rich new venture capitalist to turn to—the Bill & Melinda Gates Foundation.
Liquidia has attracted the interest in a technology for creating specific 3-D shaped particles that can be made to look like an invading virus does to the human immune system. Getting the proper shape is critically important, because it could coax the immune system to mount a defense against a particular invader. Even more importantly, Liquidia’s technique can be used to make these precise shapes, make them consistently, and do it in a scalable fashion, Holtzman says. Those are essential factors any company must figure out to make . . . .
Continue reading the article . . .
Related reading:
Solari Update _ Questions About Chemtrails
(18 May 10) Includes Quote of the Week:
The Foundation announced . . . a grant to support research [to] develop nanoparticles that penetrate the skin through hair follicles and burst upon contact with human sweat to release vaccines. ~ Press Release, Bill & Melinda Gates Foundation
Our mission is to help you live a free and inspired life. This includes building wealth in ways that build real wealth in the wider economy. We believe that personal and family wealth is a critical ingredient of both individual freedom and community, health and well-being.
Nothing on The Solari Report should be taken as individual investment, legal, or medical advice. Anyone seeking investment, legal, medical, or other professional advice for his or her personal situation is advised to seek out a qualified advisor or advisors and provide as much information as possible to the advisor in order that such advisor can take into account all relevant circumstances, objectives, and risks before rendering an opinion as to the appropriate strategy.
Be the first to know about new articles, series and events.

























































































